Individualised cancer therapeutics: dream or reality? Therapeutics construction.

about

Individualised cancer therapeutics: dream or reality? Therapeutics construction.

Item

http://www.wikidata.org/entity/Q36299931

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Individualised cancer therapeutics: dream or reality? Therapeutics construction.

@ast

Individualised cancer therapeutics: dream or reality? Therapeutics construction.

@en

type

Item

label

Individualised cancer therapeutics: dream or reality? Therapeutics construction.

@ast

Individualised cancer therapeutics: dream or reality? Therapeutics construction.

@en

prefLabel

Individualised cancer therapeutics: dream or reality? Therapeutics construction.

@ast

Individualised cancer therapeutics: dream or reality? Therapeutics construction.

@en

P1476

Individualised cancer therapeutics: dream or reality? Therapeutics construction.

@en

P2093

John Nemunaitis

http://www.w3.org/2001/XMLSchema#string

Neil Senzer

http://www.w3.org/2001/XMLSchema#string

Yuqiao Shen

http://www.w3.org/2001/XMLSchema#string

P2860

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

siRNAs generated by recombinant human Dicer induce specific and significant but target site-independent gene silencing in human cells

Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation

Vertebrate microRNA genes

Phase I evaluation of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C-alpha, in patients with advanced cancer.

Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma.

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer.

Short RNA duplexes produced by hydrolysis with Escherichia coli RNase III mediate effective RNA interference in mammalian cells

ONYX-015: mechanisms of action and clinical potential of a replication-selective adenovirus.

siRNA-mediated gene silencing in vitro and in vivo.

P304

1427-1441

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.5.11.1427

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16255647

http://www.w3.org/2001/XMLSchema#string